Making transfusion safer
Nature Medicine
December 28, 2009
A molecule has been identified that can elicit a deadly immune response after blood transfusion, as reported in this week’s Nature Medicine.
Transfusion-related acute lung injury (TRALI) is a frequent cause of death after blood transfusion. TRALI is often caused by antibodies found in blood components that are directed against a protein, HNA-3a. The identity of these antibodies has so far remained unknown.
Andreas Greinacher and colleagues now show that HNA-3a is coded by the choline transporter-like protein-2 gene, and that genetic variants in this molecule change the reactivity of the protein with HNA-3a-specific antibodies.
The molecular identification of this antigen should facilitate the development of tests for blood donor screening to lower the risk of TRALI.
doi: 10.1038/nm.2070
Research highlights
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature